The candidate must have an educational background in IT or biology, or in both which will be an advantage. An ideal candidate will be a graduate of a reputableuniversity with major in bio/IT.
RBV Capital (RBV LP) is a life sciences venture capital fund established in 2014 that invests into innovative biomedical projects
At RBV Capital we build a diversified investment portfolio composed of early to market stage products. Our investment strategy capitalises upon the coming convergence of the biological, chemical, engineering and information technologies. We are interested in biopharmaceuticals, biomedical technology and services, bioinformatics and healthcare IT, medical devices and innovative healthcare providers as well as cross-discipline companies.
Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing Musculoskeletal Pain
First Clinical Study with Novel Serotype E Botulinum Toxin Confirmed Favorable Safety and Differentiated Efficacy Profile